Kyverna
PublicKyverna is now publicly traded
The data on this page reflects Kyverna's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series B
Aug 3, 2023
Total Funding Raised
$60M
Company Overview
Kyverna (NAS: KYTX) is a biopharmaceutical company specializing in the development of innovative cell therapies for patients with autoimmune diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
CAR T-cell therapy for autoimmune diseaseautologous CD19 CAR T-cell therapycell therapy for autoimmune diseaseB-cell depleting autoimmune therapyautoimmune immune system reset therapyallogeneic CD19 CAR T-cell therapylupus nephritis cell therapymultiple sclerosis cell therapyTreg-based cell therapy platformmyasthenia gravis cell therapycell therapy for rheumatologycell therapy for neurologyengineered cell therapy development
Kyverna Comparables
Compare Kyverna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualyx | 64% | |
| Hinge Bio | 54% | |
| COUR Pharmaceuticals | 53% | |
Kyverna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 3, 2023 |
Kyverna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series B |
| jVen Capital | Series B |
| CAM Capital | Series B |
| Westlake Village BioPartners | Series B |
| GordonMD Global Investments | Series B |
| LYFE Capital | Series B |
| Vida Ventures | Series B |
Kyverna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersEmeryville, California
Employee Range155
Year Founded2018
Last FundingAug 3, 2023
See something wrong or outdated?